profit from every IDR 100 of sales.
IDR 0IDR 100
PT Jayamas Medica Industri Tbk
IDR 179.00+5.29% today
-10.5% in 1 year
1-year low IDR 162.001-year high IDR 310.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay IDR 13.18 for every IDR 1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
PT Jayamas Medica Industri Tbk vs. similar companies
PT Jayamas Medica Industri Tbk grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from IDR 100 of sales | Sales growth a year | Price per IDR 1 of profit |
|---|---|---|---|
| PT Jayamas Medica Industri Tbk | 13.2× · Cheap | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive |
AI analysis
An AI analyst reads PT Jayamas Medica Industri Tbk's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 13.2×
- –
- 1.51
- 1.9×
- 2.3×
- 17.3×
- –
- 5.8%
- 7.6%
- –
Profitability
- 34.8%
- 18.9%
- 17.8%
- –
- 12.5%
- 12.4%
- –
- –
- –
- –
Growth
- +5.9%
- +8.7%
- –
- –
- −0.0%
Financial health
- -2.1×
- 0.08
- –
- 27.5×
- 10.36
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 20%of 946
Top 26%of 871
Top 16%of 562
Bottom 31%of 867
Top 17%of 986
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
70Pass
Benjamin Graham
79Pass
Philip Fisher
60Pass
Peter Lynch
52No pass
Joel Greenblatt
50No pass
Charlie Munger
59No pass
Terry Smith
45No pass
Questions about PT Jayamas Medica Industri Tbk
Is PT Jayamas Medica Industri Tbk a good stock to buy?
A solid business, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PT Jayamas Medica Industri Tbk AI analysis
What does PT Jayamas Medica Industri Tbk do?
PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It is in Medical Instruments & Supplies.
Is PT Jayamas Medica Industri Tbk stock halal?
Yes. PT Jayamas Medica Industri Tbk passes our halal screen: its business is permitted and its debt is 4% of its market value, under the 30% limit. How we check
How has PT Jayamas Medica Industri Tbk stock done over the past year?
Down 10.5% over the past twelve months, to IDR 179.00. It traded between IDR 162.00 and IDR 310.00 and is 42.3% below its high.
Who are PT Jayamas Medica Industri Tbk's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with PT Jayamas Medica Industri Tbk's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.